The Wall Street Journal ran a lengthy article on 29 May 2013 titled "Africa's Malaria Battle: Fake Drug Pipeline Undercuts Progress." The fake medicine includes a proliferation of bogus malaria drugs in Africa that threatens to undermine years of progress in combating the disease. A study published in 2012 found that 35 percent of 2,300 malaria drug samples tested in Sub-Saharan Africa were of "poor quality"--either fake expired or badly made. Much of the bogus medicine has been traced to China, although it is difficult to pinpoint the manufacturers who sell their products through large, opaque networks.
You have to log in to the Wall Street Journal to access the entire article.